Eric Faulkner - 02 Mar 2026 Form 3 Insider Report for CNS Pharmaceuticals, Inc. (CNSP)

Signature
/s/ Christopher Downs, Attorney-in-fact
Issuer symbol
CNSP
Transactions as of
02 Mar 2026
Net transactions value
$0
Form type
3
Filing time
04 Mar 2026, 17:02:02 UTC

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Faulkner Eric Chief Technology Officer C/O CNS PHARMACEUTICALS, INC., 100 WEST LOOP SOUTH, SUITE 900, HOUSTON /s/ Christopher Downs, Attorney-in-fact 04 Mar 2026 0002113815

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney